Antibody-Drug Conjugate

Others

CGRP Receptor S1P Receptor Cannabinoid Receptor Hedgehog/Smoothened SGLT Opioid Receptor GPR CCR MT Receptor LPA Receptor PAFR OX Receptor PKA CaSR cAMP Vasopressin Receptor Protease-activated Receptor Adenosine Receptor Glucagon Receptor TAAR GRK AdipoR Prostaglandin Receptor CCK receptor GHSR Guanylate Cyclase GPCR19 GPR139 NPY receptor PAR TAS1R Sigma Receptor RGS Imidazoline Receptor Angiotensin Receptor PKG Neurokinin Receptor FPR DOCK Taste Receptor Melanocortin Receptor Somatostatin Receptor Bombesin Receptor Bradykinin Receptor CRFR GNRH Receptor TSH Receptor Parathyroid Hormone Receptor GLP-1 Receptor Adenylyl Cyclase Apelin receptor Arrestin GTPase MCHR Orphan Receptor Oxytocin Receptor Platelet aggregation RXFP receptor

All (3)
New Antibody-Drug Conjugate Products

Cat.No.

Product Name

Information

Product Use Citations

Product Validations

E0200

Trastuzumab-deruxtecan (DS-8201a, T-DXd)

Trastuzumab deruxtecan (DS-8201a, T-DXd) is an antibody-drug conjugate (ADC) composed of an anti-HER2 (human epidermal growth factor receptor 2) antibody and a cytotoxic topoisomerase I inhibitor. Trastuzumab deruxtecan shows durable antitumor activity. Trastuzumab deruxtecan has a molecular weight of 153KDa. This product is supplied as 10mg/ml PBS solution.This product is discontinued. We recommend the replacement products: D4001.

JCI Insight, 2025, 10(16)e187151

E2841

Sacituzumab-govitecan

Sacituzumab govitecan (IMMU-132) is an antibody-drug conjugate (ADC) targeting Trop-2 for delivery of SN-38, showing anticancer activity. Sacituzumab govitecan has a molecular weight of 160KDa. This product is supplied as 10mg/ml PBS solution.This product is discontinued. We recommend the replacement products: D4002.

Sci Rep, 2025, 15(1):409

Exp Dermatol, 2024, 33(10):e15196

E2851

Trastuzumab-Emtansine（T-DM1）

Trastuzumab Emtansine(T-DM1,Ado-Trastuzumab emtansine) is an antibody-drug conjugate (ADC) that incorporates the HER2-targeted antitumor properties of trastuzumab with the cytotoxic activity of the microtubule-inhibitory agent DM1.Trastuzumab emtansine has a molecular weight of 145kDa.This product is supplied as 10mg/ml PBS solution. This product is discontinued. We recommend the replacement products: D4003